Case Study

New Targets, New Drug Candidates - Agilent Bravo Platform Boosts High-throughput Screening In China

New Targets, New Drug Candidates - Agilent Bravo Platform Boosts High-throughput Screening In China

Dr. Ming Chen depends on speed and accuracy the way most of us depend on inhaling and exhaling. That’s because Chen directs a biochemistry facility that provides automated high-throughput services to all interested researchers in China. Located in Shanghai, the facility runs experiments for more than 50 research groups. “We are aiming to establish an open platform for translational research, bridging basic research to preclinical research an

Join for free to read